HealthDozens sue GLP-1 drugmakers over alleged vision loss

Dozens of people in the US are suing makers of GLP-1 drugs, alleging diabetes and weight-loss treatments caused NAION, a rare eye condition that can lead to permanent vision loss. More than 90 cases have been filed against Novo Nordisk, which says they lack merit. Research is mixed, and US regulators are still investigating the possible link.

GLP-1 drugsvision losslawsuitsdrug safety

AAl Jazeera★★★☆☆2026-09-22 15:23Original